Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth
-
Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences
-
Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial
-
Americold Realty Trust, Inc. Sets Date for Third Quarter 2026 Earnings Release and Conference Call
-
Electra Appoints General Manager to Lead Cobalt Refinery Commissioning and Operations
-
TurboGen Announces New Agreement with Leading Engineering and Manufacturing Company for Serial Development and Manufacturing of Its 20kW Systems for the Defense and Civilian Markets
-
Baker Hughes Signs Two Agreements to Develop Venezuela's Natural Gas and Energy Infrastructure
-
VisionWave Outlines Development of Autonomous Defense Ecosystem Across Tactical UAV and Counter-UAS Applications
-
Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism
-
Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases
-
DV Launches Attribution Measurement and Advances Brand Suitability for ChatGPT Ads
-
Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine
-
AIMS Surpasses 185,000 Global Active Traders, Solidifying Its Position as a Leading Regulated Prime Broker
-
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
-
Satellos Granted Composition of Matter Patent for Forazapadin
-
Dmitry Shubov Consulting Observes Cross-Border Tech and Agency Automation Trends at Cebu Summit 2026
-
Coave Therapeutics Presents Non-Human Primate Data Supporting Lead Wet AMD Gene Therapy Program at Euretina 2026
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
Wabash Schedules Third Quarter 2026 Earnings Conference Call
-
Real-World Analysis Highlighting HAE Disease Experience and Gaps in Treatment Satisfaction Published in Advances in Therapy
-
Form 8.5 (EPT/RI)-Pollen Street Group Limited
-
Form 8.5 (EPT/RI)-SThree plc
-
Preliminary data on early redemptions (prepayments)
-
Form 8.5 (EPT/RI)-Tribal Group Plc
-
SFL - Newbuild order for two Very Large Ammonia Carriers in combination with long term time charters
-
Zacatecas Silver Signs Option to Acquire the Lourdes Gold-Silver Project from Guanajuato Silver
-
Bunker Hill Starts Surface Drilling at Its Recently Acquired Page Property Intersecting 15’ of Near Surface Continuous Sulfide Mineralisation With First Hole
-
Fortrea Announces Date for Third Quarter 2026 Financial Results and Conference Call
-
LYB to discuss third-quarter results Friday, Oct. 30, 2026
-
Your Postal Code Shouldn’t Determine Your COPD Care. In Canada, It Still Does.
-
Winbuzz Announces Digital Tournament Management Focus for Local Sports in India
-
Lotus365 Announces Focus on Live Scoring for Greater Transparency in Grassroots Sports
-
Super Intelligence Q-App Offsets AI Hell Virus Across CA.gov & African Gov’t (Veterans First for America)
-
Super Intelligence Q-App Offsets AI Hell Virus Across CA.gov & African Gov’t (Veterans First for America)
-
Pan Global Awarded Spanish Government Grant to Accelerate Exploration at Escacena Copper Project, Spain
-
Prepayments (CK93) - Totalkredit A/S
-
Prepayments (CK93) - Nykredit Realkredit A/S
-
Transaction in Own Shares
-
Heineken Holding N.V. reports transactions under its current share buyback programme
-
Athabasca Oil Announces Agreement to be Acquired by Cenovus Energy
-
Liberty Gold Strengthens Black Pine Development Team with the Appointment of Curtis Cadwell as General Manager
-
Vaxcyte Reports Positive Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate Vaccine Candidate
-
Cenovus announces agreement to acquire Athabasca Oil Corporation
-
Copper Mountain Technologies to Showcase BFx-02 Frequency Extension Base, Cross-Platform Software, and Integrated VNA Solutions at EuMW 2026
-
KBR to Hold Third Quarter Earnings Conference Call
-
Man Group PLC : Form 8.3 - Rotork plc
-
Man Group PLC : Form 8.3 - Senior plc
-
Man Group PLC : Form 8.3 - Spire Healthcare Group Plc
-
Man Group PLC : Form 8.3 - Sthree plc
-
Man Group PLC : Form 8.3 - Vesuvius Plc
